Europese Unie - Nederlands - EMA (European Medicines Agency)

actavis group ptc ehf - reteplase - myocardinfarct - antitrombotische middelen - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kela pharma sa-nv - lithiumcarbonaat 250 mg - omhulde tablet - 250 mg - lithiumcarbonaat 250 mg - lithium